Arrowhead Pharmaceuticals (ARWR) Cash & Current Investments (2010 - 2026)
Arrowhead Pharmaceuticals' Cash & Current Investments was $1.6 billion in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 77.9% from $900.37 million a year earlier but down 10.2% from the prior quarter.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Cash & Current Investments at Arrowhead Pharmaceuticals came in at $919.37 million, up 35.0% from FY2024.
- Cash & Current Investments has now increased for five consecutive fiscal years, with a five-year compound annual growth rate of 31.9% (FY2020 to FY2025).
- In earlier fiscal years, Cash & Current Investments was $680.96 million in FY2024 (+68.7%), $403.63 million in FY2023 (+7.2%), $376.4 million in FY2022 (+21.0%) and $311.16 million in FY2021 (+35.0%).
- Quarterly Cash & Current Investments has moved between $217.61 million (fiscal Q1 2022) and $1.78 billion (fiscal Q2 2026) over five years.
- Compared with a year earlier, Cash & Current Investments has increased for eight straight quarters, with growth averaging 84.6% over the last eight quarters.
- The best year-over-year quarter for Cash & Current Investments over five years was fiscal Q1 2025 (growth of 151.0%); the worst was fiscal Q1 2024 (a decline of 56.1%).
- Per Business Quant data, ARWR's Cash & Current Investments in the three fiscal quarters before Q3 2026 was $1.78 billion (Q2 2026), $916.64 million (Q1 2026) and $919.37 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Arrowhead Pharmaceuticals | 9.06 Bn | 3.84 Bn | - | 1.60 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.60 Bn |
| Mar 31, 2026 | 1.78 Bn |
| Dec 31, 2025 | 916.64 Mn |
| Sep 30, 2025 | 919.37 Mn |
| Jun 30, 2025 | 900.37 Mn |
| Mar 31, 2025 | 1.10 Bn |
| Dec 31, 2024 | 552.94 Mn |
| Sep 30, 2024 | 680.96 Mn |
| Jun 30, 2024 | 436.70 Mn |
| Mar 31, 2024 | 523.11 Mn |
| Dec 31, 2023 | 220.32 Mn |
| Sep 30, 2023 | 403.63 Mn |
| Jun 30, 2023 | 451.73 Mn |
| Mar 31, 2023 | 481.01 Mn |
| Dec 31, 2022 | 501.85 Mn |
| Sep 30, 2022 | 376.40 Mn |
| Jun 30, 2022 | 416.54 Mn |
| Mar 31, 2022 | 279.32 Mn |
| Dec 31, 2021 | 217.61 Mn |
| Sep 30, 2021 | 311.16 Mn |
API Access
Arrowhead Pharmaceuticals Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();